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We describe a strategy for exploring the function of protein-protein interactions in striated
muscle in vivo. We describe our experience using this strategy to study the interaction
of UNC-112 (kindlin) with PAT-4 (integrin linked kinase). Random mutagenesis is used to
generate a collection of mutants that are screened for lack of binding or gain of binding
using a yeast 2-hybrid assay. The mutant proteins are then expressed in transgenic
C. elegans to determine their ability to localize in the sarcomere. We emphasize two
advantages of this strategy: (1) for studying the interaction of protein A with protein B,
when protein A can interact with multiple proteins, and (2) it explores the function of an
interaction rather than the absence of, or reduced level of, a protein as can be obtained
with null mutants or knockdown by RNAi. We propose that this method can be generalized
for studying the meaning of a protein-protein interaction in muscle for any system in which
transgenic animals can be generated and their muscles can be imaged.
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BACKGROUND—UNC-112 (KINDLIN) AND PAT-4 (ILK)
The model genetic system C. elegans is an excellent platform
for learning new information about striated muscle, including
new components of the sarcomere, requirements for assem-
bly and maintenance of the sarcomere, and mechanisms of the
regulation of the contraction/relaxation cycle (Waterston, 1988;
Moerman and Fire, 1997; Moerman and Williams, 2006; Qadota
and Benian, 2010). Because of the evolutionary conservation of
sarcomere structure and components, these studies in C. elegans
have relevance to our understanding of the inherited cardiomy-
opathies, most of which are due to mutations in sarcomere
proteins (Benian and Epstein, 2011; Epstein and Benian, 2012).
In C. elegans the myofibrils are organized such that all thick
filament organizing centers (M-lines) and thin filament attach-
ment sites (dense bodies analogous to Z-disks) are anchored to
the muscle cell membrane. These integrin-based muscle adhe-
sion sites are ideal models for costameres of vertebrate striated
muscle and focal adhesions of non-muscle cells. Many compo-
nents of C. elegans myofibrils and their attachment structures
have been defined. Most were first identified through mutation—
most falling into one of two phenotypic classes. In one class, the
uncoordinated or “Unc” class, due to mutation in any one of
∼40 genes, animals develop into adults but they are slow mov-
ing or paralyzed (Waterston et al., 1980; Zengel and Epstein,
1980). The second class, called “Pats” (paralyzed arrested at two-
fold) result from mutation in one of 20 genes; embryos do
not move in the eggshell and elongation arrests at the two-fold
embryonic stage (Williams and Waterston, 1994; Meissner et al.,
2009).
Our laboratory has helped discover an interacting network of
proteins that extend from integrin in the muscle cell membrane
inward toward myosin at M-lines, and actin at dense bodies
(Qadota and Benian, 2010; Warner et al., 2011, 2013; Lecroisey
et al., 2013). One component of the attachment structures is
UNC-112 (kindlins in mammals). UNC-112 is part of a con-
served four-protein complex that associates with the cytoplasmic
tail of integrin. Although a kindlin was first discovered in humans
in 1994 (Wick et al., 1994), it was not until the description of
UNC-112 in 2000 (Rogalski et al., 2000) that we learned that
kindlins have a role in integrin adhesion complexes. In contrast
to C. elegans, which has one kindlin (UNC-112), humans have
three kindlins, each encoded by a separate gene (Meves et al.,
2009). Inherited mutations in kindlin-1 result in a serious skin
disease (Kindler syndrome) (Siegel et al., 2003), and mutations in
kindlin-3 result in severe dysfunction of both platelets and leuko-
cytes (leukocyte adhesion deficiency type III) (Moser et al., 2009;
Svensson et al., 2009). Kindlin-2 is expressed in the heart and
localized to intercalated disks and costameres. Loss of function
of kindlin-2 in zebrafish results in severe abnormalities of heart
development and function (Dowling et al., 2008).
In embryonic muscle, proper localization of UNC-112 to inte-
grin adhesion sites requires PAT-4 (the nematode ILK ortholog)
(Rogalski et al., 2000); the converse is also true: the proper local-
ization of PAT-4, requires UNC-112 (Mackinnon et al., 2002).
We sought to understand the molecular basis of this require-
ment.We used the cytoplasmic tail of PAT-3 (β-integrin) as bait to
screen a yeast 2-hybrid library of C. elegans cDNAs, and recovered
as the only interacting protein, UNC-112 (Qadota et al., 2012).
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This interaction was confirmed in two ways: (1) glutathione
agarose beads coated with GST-PAT-3, but not GST, were able
to pull out UNC-112 from a worm lysate; and (2) similar beads
were able to bind to purified bacterially expressed MBP-UNC-
112-His. When the C-terminal half of UNC-112 was used to
screen the 2-hybrid library, all positive clones were cDNAs encod-
ing UNC-112. Additional 2-hybrid and in vitro binding data
indicate that the N-terminal and C-terminal halves of UNC-112
interact with each other. By either 2-hybrid or in vitro bind-
ing assays, PAT-4 does not interact with the cytoplasmic tail of
PAT-3. PAT-4 was shown to interact with the N-terminal half of
UNC-112 (Mackinnon et al., 2002) (Figure 1). All these data led
us to hypothesize that UNC-112 exists in closed inactive, and
open active conformations; that binding of PAT-4 to the UNC-
112 N-terminal half results in an opening up of UNC-112, and
consequent binding of the UNC-112/PAT-4 complex to the cyto-
plasmic tail of PAT-3 (Qadota et al., 2012) (Figure 2). In support
of this model, we could demonstrate competition between the
UNC-112 C-terminal half and PAT-4 for binding to the UNC-112
N-terminal half (Qadota et al., 2012).
Our model that UNC-112 engages in intramolecular inter-
action to form a closed conformation is compatible with the
phenomenon of intramolecular masking of other ERM proteins
such as ezrin, radixin and moesin, which like UNC-112 con-
tain a FERM domain. In the case of ERM proteins, the FERM
domain is unable to interact with membrane proteins when it is
bound to its ∼100 residue C-terminal tail (Reczek and Bretscher,
1998). It should also be pointed out that the complete structure
of any kindlin family protein has not been reported. We only
know the structures of two small portions of kindlins; there is an
NMR structure of the ∼100 residue N-terminus (or Fo domain)
of mouse kindlin-1 (Goult et al., 2009), an NMR structure (Liu
FIGURE 1 | Schematic representation of UNC-112 indicating predicted
domains, mutation sites, and interaction with PAT-4. Domains of each
protein, indicated by colored rectangles were predicted by PFAM, with
boundaries indicated by residue numbers. The black and red brackets
indicate the minimal regions that are required for interaction of UNC-112
with PAT-4, respectively. In UNC-112, the D382V mutation prevents
UNC-112 from interacting with PAT-4; the T346A and the E349K mutations
each prevent interaction of the N-terminal half of UNC-112 with the
C-terminal half of UNC-112. The blue bracket denotes the 30 residue region
(633–663) containing 5 residues that when mutated singly permit the
N-terminal half of UNC-112 containing T346A to interact with the C-terminal
half of UNC-112.
et al., 2011) and a preliminary crystal structure (Lee et al., 2011)
of the 100 residue PH domain human kindlin-2, and a crystal
structure of the PH domain of mouse kindlin-1 (Yates et al.,
2012b). Recently, SAXS analysis of mouse kindlin-3 has been
reported (Yates et al., 2012a). The proposed model suggests that
the two halves of FERM-M (aka F2 and F3) that are split by the PH
domain, are physically next to each other. Since these two halves
are in the N- and C-terminal halves of these molecules, the SAXS
data is compatible with our “closed conformation” model.
EVALUATION OF THE MEANING OF PROTEIN-PROTEIN
INTERACTION In vivo
If our model was correct, we reasoned that an UNC-112 mutant
that cannot bind to PAT-4, would not localize to muscle adhesion
sites in vivo. We screened for an UNC-112 mutant protein that
cannot bind to PAT-4 by yeast 2-hybrid assay, and then tested for
its localization by generating and analyzing transgenic worms.
Error prone PCR (Cadwell and Joyce, 1992) was used to introduce
mutations randomly into the N-terminal half of UNC-112, the
portion of UNC-112 known to interact with PAT-4. In order for
PCR to introduce more than the usual errors, the fidelity of Taq
DNA polymerase is decreased by modifying the reaction mixture
to contain Mn2+ (0.5mM) and increasing the concentration of
Mg2+ (e.g., to 7.5mM). Varying the amount of template DNA,
empirically, controls the extent ofmutagenesis. The concentration
of template is inversely proportional to the level of mutations; a
low level of template results in more mutations.
The PCR primers had 30 nt of sequence that overlapped a
linearized 2-hybrid prey plasmid containing the wild type C-
terminal half of UNC-112. A mixture of the PCR fragment and
linearized prey, was transformed into yeast harboring a bait plas-
mid containing the cytoplasmic tail of PAT-3. Generation of
full-length UNC-112 prey clones occurred via recombination in
the yeast cells, due to the 30 bp of overlapping sequence (Takita
FIGURE 2 | Conformation-based model for the interaction of UNC-112
with integrin. Based on yeast 2-hybrid, biochemical and mutational
analysis, it is hypothesized that UNC-112 exists in two conformations,
closed and open, and that only the open form can interact with the
cytoplasmic tail of integrin at the base of adhesion sites in muscle. Further,
the conversion to the open active form is promoted by binding of UNC-112
to PAT-4. (modified from Qadota et al., 2012).
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et al., 1997). Transformed yeast cells were placed onto selective
media, and those that grew indicated interaction between mutag-
enized UNC-112 and PAT-3. This step was crucial for eliminating
clones with premature stop mutations or other trivial reasons.
From 86 colonies, the PAT-3 bait was eliminated, and the UNC-
112 prey plasmids were isolated. These UNC-112 prey clones were
transformed separately into yeast strains carrying either the PAT-
3 bait, or the PAT-4 bait. From the 86 UNC-112 preys, 32 preys
showed interaction with PAT-3, and one showed no interaction
with PAT-4. This clone had two mutations—R73L and D382V.
Prey clones of UNC-112 harboring each of these single amino
acid changes were generated and tested for PAT-4 binding: only
D382V eliminated binding to PAT-4 (Figure 1). The N-terminal
half of UNC-112 containing D382V continued to interact with a
wild type version of the C-temrinal half of UNC-112.
We then used a heat shock promoter to express in wild type
C. elegans HA tagged versions of wild type and D382V UNC-112.
By western blot using anti-HA, we could detect stable expression
of both wild type and D382V UNC-112. By immunofluorescence
microscopy using anti-HA, although wild type HA-UNC-112 was
properly localized to muscle adhesion sites, D382VHA-UNC-112
was not localized, thus fulfilling our expectation (Figure 3A).
We next reasoned, that if our model that only an open con-
formation of UNC-112 can bind to PAT-3, then mutations that
block the interaction between the N- and C-terminal halves of
UNC-112 (constitutively open), might allow D382V UNC-112 to
properly localize (Figure 2). Using a similar strategy as described
above, random mutations were introduced into UNC-112 N-
terminal half, and colonies were screened by yeast 2-hybrid assays
for those that interacted with PAT-4, but failed to interact with
the UNC-112 C-terminal half. Ninety-three recominated plas-
mids were obtained, and of these, 87 showed interaction with
PAT-4, but 13/87 failed to bind to the UNC-112 C-terminal half.
Two plasmids had single residue changes—T346A and E349K
(Figure 1). Single and double mutants (with D382V) were gen-
erated in full length UNC-112, and tested by 2-hybrid: all bound
to PAT-3, and either T346A or E349K bind to PAT-4; only when
D382V was added was binding to PAT-4 abolished. The single and
double mutant UNC-112 proteins were also ectopically expressed
from a heat shock promoter, and the proteins detected with
anti-HA by immunofluorescence. All single and double mutants
localized tomuscle adhesions sites. Therefore, mutations that pre-
vent the N- to C-terminal interaction bypass the requirement of
UNC-112 to bind to PAT-4 for proper localization of UNC-112.
It should be pointed out that the isolation of specific
non-bindingmutantsoccursatahighenoughfrequencytobeprac-
tical. In our experience, on average, from about 50 mutagenized
fragments without premature stops, one or two specific non-
binding mutants were isolated. In the cases presented here, we
isolatedonePAT-4non-bindingUNC-112mutantfrom32mutants
that retained binding to PAT-3, and we recovered 2 C-terminus
non-binding mutants of UNC-112 from 87 PAT-4 binding N-
terminalmutagenized fragments.A similar ratio has been reported
for other types of specific loss-of-function screens in yeast. In
the case of yeast conditional lethals (for example, temperature
sensitivemutants) screening, for threegenes (RHO1,MSS4,FKS1),
temperature sensitive mutants were isolated at a similar ratio
(Homma et al., 1998; Saka et al., 2001; Okada et al., 2010).
A SUPPRESSOR MUTATION APPROACH FOR FINDING
BINDING INTERFACES
INTERMOLECULAR INTERACTION
Because the structure of an UNC-112 (kindlin)/PAT-4 (ILK) has
not yet been solved, we decided to take a suppressor mutation
approach for revealing an interaction surface for these two pro-
teins. As before, we screened formutations with the yeast 2-hybrid
system, and then tested them in the striated muscle of transgenic
nematodes. Beginning with the D382V UNC-112 mutant pro-
tein that cannot bind to PAT-4, we sought to isolate “suppressor”
mutations in PAT-4 that would allow binding to D382V UNC-
112. If successful, we also would have the opportunity to further
test our conformational model for the requirement of UNC-112
to bind to PAT-4 in order to have proper localization of UNC-112
tomuscle integrin adhesion sites: although D382VUNC-112 can-
not localize, a D382V UNC-112 in the presence of a suppressor
PAT-4 protein, might localize (Figure 3B).
Using the same general method as described above, we ran-
domly mutagenized full length PAT-4, and screened for PAT-4
mutants than can bind to D382V UNC-112 (Qadota et al., 2014).
Upon screening 12,700 colonies, initially 62 were positive for this
interaction. Upon re-transformation, 40/62, remained positive.
After determining the DNA sequences of 37 such PAT-4 clones,
5 were single amino acid changes, and the others had 2–5 changes
each. By comparing these clones with multiple changes, and using
in vitro mutagenesis to make clones with single residue changes,
the total number of clones with missense mutations in single
unique residues totaled 9. It is noteworthy that although the entire
PAT-4 sequence was mutagenized, all of these mutations reside in
the kinase domain, the minimal region required for interaction
with UNC-112 (Figure 1).
Fukuda et al. (2009) have reported the crystal structure of
human ILK (PAT-4) kinase domain bound to part of α-parvin
(PAT-6 in nematodes; Lin et al., 2003). Based on this structure,
we developed a homology model of the PAT-4 kinase domain and
located the residues mutated in our PAT-4 suppressors. The sup-
pressor mutations cluster in 2 regions on the surface of PAT-4:
6 cluster near the edge of the beta sheet and helix-1 in the N-
terminal subdomain, and 3 cluster in helices of the C-terminal
subdomain (Qadota et al., 2014). When PAT-4 was substituted for
ILK in the ILK/α-parvin complex, α-parvin, and by implication,
PAT-6, did not overlap or cover either cluster of PAT-4 suppres-
sor residues. Therefore, either cluster or both could constitute
binding surfaces for UNC-112. Moreover, one of the PAT-4 sup-
pressor mutations could permit localization of D382V UNC-112
to integrin adhesion sites in nematode muscle: co-expression of
HA-UNC-112 D382V with myc-PAT-4 wild type does not show
localization, but HA-UNC-112 D382V with myc-PAT-4 P257L,
does show localization (Qadota et al., 2014).
INTRAMOLECULAR INTERACTION
Beginning with T346A and E349K UNC-112 (in the N terminal
half of UNC-112) that cannot bind to wild type UNC-112 C ter-
minal half, we mutagenized the C terminal half and screened for
compensatory mutations that permit T346A UNC-112 to bind
to UNC-112 C terminal half. Nine UNC-112 C terminal half
mutants containing missense mutations were isolated (Qadota
et al. unpub. data). Three of these contained single missense
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FIGURE 3 | Generalized description of the method. (A) Isolation and
characterization of a mutant in protein A that does not bind to protein B.
From top to bottom: protein A is known to interact with protein B. Random
mutagenesis is used to generate a collection of protein A mutants
(mutations indicated by ∗ at various positions in the protein), and these are
tested by yeast 2-hybrid assays for interaction with protein B. One or more
such protein A mutants (∗ and purple) is found to not interact with protein
B (denoted by a red X). Transgenic animals are generated that express either
(Continued)
FIGURE 3 | Continued
wild type protein A (blue), or mutant protein A (purple), each with an
immunotag (e.g., HA, as shown). These transgenic animals are used in two
types of experiments. As indicated below, using an antibody that detects
the immunotag, the requirement of the interaction of protein A with protein
B for localization of protein A, is assessed by immunofluorescent detection
in muscle. An example of such a wild type and mutant protein A is UNC-112
(kindlin) in C. elegans muscle, and is shown. Wild type UNC-112 localizes
normally to dense bodies (dots) and M-lines (lines), but D382V UNC-112
which does not interact with protein B (in this case, PAT-4), fails to localize
(modified from Qadota et al., 2012). As indicated to the right, these
transgenic animals are used to assess whether mutant protein A (∗ and
purple) can bind to protein B in vivo: protein extracts are prepared from
each type of transgenic animal, and immunotagged protein A (wild type,
blue, or mutant, purple) is immunoprecipitated (IP) with anti-tag conjugated
beads, washed, eluted and then protein B is detected by immunoblot. An
example is shown for the UNC-112/PAT-4 interaction in C. elegans (modified
from Qadota et al., 2012). (B) Isolation and characterization of mutations in
protein B that restore interaction of protein B with a mutant version of
protein A. From top to bottom: a mutant form of protein A (∗ and purple)
does not interact with protein B. Random mutagenesis is used to generate
a collection of protein B mutants (indicated by #), and these are tested by
yeast 2-hybrid assays for interaction with protein A∗. One or more such
protein B mutants (# and orange) are found to interact with protein A∗
(denoted by an arrow). Transgenic animals are generated that express
mutant protein A∗ (purple), with either wild type protein B (yellow), or
mutant protein B# (orange). Note that protein A and protein B are
expressed with different immunotags (e.g., HA or myc, as indicated). These
transgenic animals are used in two types of experiments. As indicated
below, using an antibody that detects the immunotag for protein A∗, the
ability of mutant protein B# to restore the ability of protein A∗ to localize in
muscle, is assessed by immunostaining. As indicated to the right, these
transgenic animals are used to assess whether mutant protein B (# and
orange) can restore the ability of protein B to interact with mutant protein A
(∗ and purple) in vivo: protein extracts are prepared from each type of
transgenic animal, and immunotagged mutant protein A (∗ and purple) is
immunoprecipitated (IP) with anti-tag conjugated beads, washed, and
eluted and then protein B is detected by immunoblot.
mutations (S644C, N659D, R663Q). In addition, two other muta-
tions (R633Q and I662T) occurred repeatedly in the multiply
mutant isolates. When these mutations were tested alone, they
were each found to have the suppressor activity. All five residues
mutated lie in a 30-residue span (633–663)(Figure 1). All five
allow binding to either T346A or E349K UNC-112 N-terminal
half proteins. Our interpretation is that residues within the region
633–663 contact residues in 346–349, in the closed conformation
of wild type UNC-112. Two of the five residues (R633 and N659)
are conserved in human kindlins -1, -2, and -3. Validation of this
interpretation awaits determination of the structure of UNC-112,
which is currently being pursued.
This type of “positive screening” or “gain-of-function screen-
ing” is easier than the previously described “negative screen-
ing” (for non-binding mutants). To identify missense mutants
that are non-binding, mutagenized fragments without premature
stops first need to be recovered. However, for “positive screen-
ing,” this step is not required, since a “positive reaction” (i.e.,
protein interaction) already excludes premature stops or other
severe mutations. “Gain-of-function” suppressors are useful for
identifying interactingmolecules (for a classic example see Adams
et al., 1989). In our case, “gain-of-function” suppressors in PAT-4,
starting with a non-binding mutant that has a single amino
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change in UNC-112, was useful for identifying an interacting
surface on PAT-4 for two reasons. First, the single amino acid
change in the non-binding mutant of UNC-112 is not likely to
result in a large conformational change, so that it was more prob-
able that a single amino acid change on the interacting surface of
PAT-4 could restore interaction. Second, the random mutagene-
sis made it possible to identify many such suppressors. Indeed,
for the UNC-112-PAT-4 interaction, we identified 9 single amino
acid changes, and then after finding that these residues map onto
two clusters of a homology model of PAT-4, inferred one or two
binding surfaces.
BROADER APPLICATIONS OF THE METHOD
In the model genetic organisms, such as S. cerevisiae, C. ele-
gans, and Drosophila, genetic deletions are available and in other
systems, knock down by siRNA are available. However, to ask
the meaning of protein-protein interactions, deletions or knock
downs, resulting in the absence or reduction in level of one pro-
tein in vivo, is not ideal. One reason is that deletions or knock
downs often cause pleiotropic effects. For example, in the case
of unc-112 and pat-4, the null mutants stop development at
an embryonic stage, so we cannot examine the effect of these
mutants in adult stage muscle, in which structures are more well-
defined and amenable to microscopic analysis. Expression of our
non-binding mutants in adult stage muscle allows us to examine
the function of these protein in the adult stage, but also allows us
to examine the essentiality of a protein interaction rather than
the essentiality of expression of the protein. Another reason is
that some proteins interact with many proteins, so that complete
absence of a protein or reduced levels of a protein can result in
multiple effects. For example, PAT-4 binds to PAT-6 and UNC-97,
not just to UNC-112. Thus, in pat-4 null mutants, interactions
with PAT-6 or UNC-97 are also abolished, so it is impossible to
ask the meaning of the absence of UNC-112 interaction with this
type of mutant. In muscle, there are several giant polypeptides
(>400,000Da) consisting of many domains. For example, in C.
elegans muscle, UNC-89 (the homolog of obscurin in mammals)
has been reported to interact with a number of proteins (CPNA-
1, MEL-26, LIM-9, and SCPL-1) (Qadota et al., 2008; Xiong et al.,
2009; Wilson et al., 2012; Warner et al., 2013). Severe loss-of-
function alleles of unc-89 also abolish all these interaction, so it
would be impossible to determine the meaning of each of these
individual protein-protein interactions. One strategy would be to
isolate an unc-89 mutant that cannot bind to a specific interac-
tor. Reciprocally, we could use methods described here to isolate
mutants in an interactor that cannot bind to UNC-89, and after
expression in transgenic worms, determine the function of this
interaction.
Our strategy for studying protein-protein interactions impor-
tant for the muscle sarcomere can be generalized, as depicted
in (Figure 3). This strategy can be utilized in any model sys-
tem in which transgenics are easily generated and muscle can
be easily visualized, such as Drosophila, zebrafish, and perhaps
Xenopus. Indeed, the strategy can be extrapolated to study any
protein-protein interaction that occurs in any large cellular struc-
ture that can be imaged by light microscopy, for example, synaptic
terminals of neurons, or desmosomes of epithelial cells. Here is
one example for vertebrate striated muscle: an obscurin isoform,
expressed in mouse heart, can be extensively studied in cultured
mouse cardiomyocytes. A yeast 2-hybrid screen has revealed that a
small segment of this obscurin interacts with protein X. In addi-
tion, obscurin and protein X localize to the same regions of the
sarcomere (M-lines and Z-disks), and the proper localization of
protein X depends on the presence of obscurin (e.g., RNAi medi-
ated knockdown of obscurin, results in mis-loclization of protein
X). However, because obscuring is a huge multi-domain pro-
tein with many known and expected interactors, this knockdown
will also disrupt the localization of many interacting proteins.
Random mutatgenesis and yeast 2-hybrid assays are used iso-
late a missense mutation in protein X (∗), such that protein X∗
does not interact with obscurin. Transient transfection is used
to express in cardiomyocytes, tagged versions of either wild type
or ∗ mutant protein X, and the tagged versions of these proteins
are detected with anti-tag antibodies. Results might show that
wild type protein X localizes, but ∗ mutant protein X does not
localize. This strategy demonstrates that interaction of a specific
region of obscurin is required for the localization of a particu-
lar protein. Such information cannot be obtained by using simple
knockdown or even mutations that result in reduced levels or
elimination of this obscurin isoform.
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